Barclays’s Artiva Biotherapeutics, Inc. Common Stock ARTV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$3K	Sell	1,906 -20,847	-92%	-$32.8K	﹤0.01%	4255
2025 Q1	$68K	Sell	22,753 -1,408	-6%	-$4.21K	﹤0.01%	3805
2024 Q4	$244K	Buy	24,161 +4,545	+23%	+$45.9K	﹤0.01%	3426
2024 Q3	$304K	Buy	+19,616	New	+$304K	﹤0.01%	3279